Sarepta Therapeutics Terminates Chief Science Officer As It Heads Toward Drug Approval
Published: Jul 25, 2014
Sarepta Therapeutics disclosed in a federal filing that on Tuesday its chief scientific officer was terminated from his position.
Arthur Krieg was hired to the company just six months ago as senior vice president and chief scientific officer. The filing with the Securities and Exchange Commission early Thursday morning gave no reason for the termination, and the company did not immediately respond to an email seeking comment on Thursday morning.
Help employers find you! Check out all the jobs and post your resume.